Acer Therapeutics Tries To Shake Suit Over FDA Rejection
Acer Therapeutics is pushing a New York federal court to dump a proposed shareholder class action accusing the small pharmaceutical company of misrepresenting expectations for a new drug to get U.S....To view the full article, register now.
Already a subscriber? Click here to view full article